TransCardiac Therapeutics, Inc. — Form D

TransCardiac Therapeutics, Inc. of ATLANTA, GA, a company, filed a Form D exempt-offering notice with the SEC on 2009-07-30. The offering totals $3.0M, of which $200K was reported sold. Industry: Other Health Care.

Offering

• Filed: 2009-07-30
• Form: D
• Accession: 0001464911-09-000003
• Industry: Other Health Care
• Exemptions: 06, 46
• Total offering: $3.0M
• Amount sold: $200K
• Remaining: $2.8M
• Minimum investment: $100K
• Investors: 1
• Date of first sale: 2009-07-24
• Security types: equity
• Revenue range: $1 - $1,000,000
• SEC file number: 021-133215

Issuer

• Name: TransCardiac Therapeutics, Inc.
• CIK: 0001464911
• Entity type: Corporation
• Jurisdiction: GEORGIA
• Incorporated: 2007
• Address: 3355 LENOX ROAD NE SUITE 415, ATLANTA, GA, 30326
• Phone: 404-816-4520

Officers, directors & promoters (11)

More

• CIK 1464911 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search